During the past decade, University of North Carolina AIDS Clinical Trials Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Carolina AIDS Clinical Trials Unit" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Copenhagen HIV Programme (CHIP) -- Copenhagen, Denmark" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "University of North Carolina AIDS Clinical Trials Unit" are "HIV Infections" (3 trials), "Genital Herpes Simplex Type 2" (2 trials), "Acquired Immunodeficiency Syndrome" (1 trials), "HIV" (1 trials) and "HIV Infection" (1 trials). Many other conditions were trialed in "University of North Carolina AIDS Clinical Trials Unit" in a lesser frequency.

Most popular intervention types in "University of North Carolina AIDS Clinical Trials Unit" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "E/C/F/TAF" (2 trials), "E/C/F/TDF" (2 trials), "E/C/F/TDF Placebo" (2 trials), "GEN-003 Vaccine (30μg of each antigen)" (2 trials) and "GEN-003 Vaccine (60μg of each antigen)" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of North Carolina AIDS Clinical Trials Unit" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of North Carolina AIDS Clinical Trials Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in University of North Carolina AIDS Clinical Trials Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of North Carolina AIDS Clinical Trials Unit, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".